Skip to content
Denali Therapeutics Inc icon

Denali Therapeutics Inc

DNLIStocksBiotechnologyUnited StatesNasdaqUSD

Price

$19.28

Today

-3.2%

YTD

+17.0%

About

Denali Therapeutics, Inc, is a company in the biotechnology sector, focusing on combatting neurodegenerative diseases by devising effective therapeutic solutions. The company operates globally, focusing its research on biomedical advancement. Based in the biopharmaceutical industry, Denali Therapeutics navigates both the healthcare and pharmaceutical sectors, providing scientific research and clinical drug development. Though it stands alone as an independent entity, its reputation is advanced by its numerous collaborations within the medical community, helping combat diseases such as Alzheimer's and Parkinson's. Monitor the DNLI share price by adding it to your eToro watchlist.

Price chart
Closing price history for DNLI (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-7.02
P/S (TTM)1034.80
P/B (TTM)3.81
Market cap$3.18B
Cap tierMid-cap
Industry avg P/E-1.91

Profitability

Gross margin-318.04%
EBIT margin-15058.19%
Net margin-3539.21%
ROE-54.93%
ROA-44.01%

Earnings & Revenue

Revenue (TTM)$3.60M
Revenue growth (1Y)-100.0%
EPS (TTM)-$2.84
Free cash flow$-437.46M
Total debt$37.69M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.67
Employees503
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.